Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Intra-Cellular Therapies Prices Public Offering of Common Stock
-
Intra-Cellular Therapies to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Intra-Cellular Therapies Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
-
Intra-Cellular Therapies Announces Closing of $150 Million Public Offering of Common Stock
-
Intra-Cellular Therapies (ITCI) Prices 9.68M Share Common Offering at $15.50/Sh
-
Intra-Cellular Therapies Prices $150 Million Public Offering of Common Stock
-
Intra-Cellular Therapies to Participate at Upcoming Investor Conferences
-
Intra-Cellular Therapies (ITCI): Future Cloudier - Cantor
-
Cantor Fitzgerald Starts Intra-Cellular Therapies (ITCI) at Overweight
-
Intra-Cellular Therapies to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
